NRP1 and systemic lupus erythematosus: To further evaluate the presence of pDCs in the skin biopsies, staining for BDCA-4 (CD304) was performed using immunofluorescence in non-lesional skin biopsies acquired from healthy controls (n = 3), At-Risk individuals (n = 3), and patients with SLE (n = 3).